0A Phase 2 Open-Label, Multicenter Clinical Study of the

Project: Research project

Description

A Phase 2 Open-Label, Multicenter Clinical Study of the Safety and Efficacy of SNS-595 Injection in Patients at least 60 Years of Age with Previously Untreated Acute Myeloid Leukemia
StatusFinished
Effective start/end date3/1/0810/31/11

Funding

  • Sunesis Pharmaceuticals, Inc.

Fingerprint

Acute Myeloid Leukemia
Multicenter Studies
Safety
Injections
Clinical Studies
vosaroxin